YiChang HEC ChangJiang Pharmaceutical Co. Ltd.
http://www.hec-changjiang.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From YiChang HEC ChangJiang Pharmaceutical Co. Ltd.
Roche’s Xofluza Can Reduce Flu Transmission, Giving It Potential Market Boost
The company said the CENTERSTONE study marked the first time a global Phase III trial showed reduced transmission of influenza.
China’s First Insulin Tender Hits Multinationals Hard
An average overall price reduction of 48% for insulin products in China is expected to generate annual savings of $1.4bn through 2023, but multinational pharma firms will be hit hard by the bidding process.
Chi-Med's Surufatinib, Generic Ibrance Among Latest China Approvals
China's innovative drug makers step into the spotlight by grabbing green lights for cancer drugs in the country's latest batch of product approvals.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice